Precigen (PGEN) Depreciation and Depletion (2012 - 2026)
Precigen (PGEN) reported Depreciation and Depletion of $781000.0 for Q1 2026, up 151.94% year-over-year from $310000.0 in Q1 2025, and down 4.64% quarter-over-quarter from $819000.0 in Q4 2025.
Precigen (PGEN) Depreciation and Depletion (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Depreciation and Depletion data on file, last reported at $781000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $781000.0, up 151.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 71.58% YoY), and the FY2025 annual result was $1.9 million, up 31.29% from the prior year.
- Depreciation and Depletion fell to $781000.0 in Q1 2026 per PGEN's latest filing, from $819000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $819000.0 in Q4 2025 and troughed at $310000.0 in Q1 2025.
- A 5-year average of $493352.9 and a median of $475000.0 in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2022 and 2026: Depreciation and Depletion sank 59.01% in 2022, then jumped 151.94% in 2026.
- A 5-year view of Depreciation and Depletion shows it stood at $560000.0 in 2022, then decreased by 27.68% to $405000.0 in 2023, then decreased by 15.31% to $343000.0 in 2024, then jumped by 138.78% to $819000.0 in 2025, then slipped by 4.64% to $781000.0 in 2026.
- Business Quant data shows PGEN's Depreciation and Depletion at $781000.0 in Q1 2026, $819000.0 in Q4 2025, and $485000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | 781,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 781,000.00 |
| Mar 31, 2026 | 781,000.00 |
| Dec 31, 2025 | 819,000.00 |
| Dec 31, 2025 | 819,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Dec 31, 2024 | 343,000.00 |
| Dec 31, 2024 | 343,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 405,000.00 |
| Dec 31, 2023 | 405,000.00 |